Cigna Group $CI Shares Sold by Robeco Institutional Asset Management B.V.

Robeco Institutional Asset Management B.V. lowered its stake in Cigna Group (NYSE:CI) by 11.2% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 84,665 shares of the health services provider’s stock after selling 10,664 shares during the period. Robeco Institutional Asset Management B.V.’s holdings in Cigna Group were worth $23,302,000 at the end of the most recent reporting period.

Other institutional investors have also modified their holdings of the company. Brighton Jones LLC grew its holdings in Cigna Group by 9.3% during the fourth quarter. Brighton Jones LLC now owns 3,736 shares of the health services provider’s stock worth $1,032,000 after acquiring an additional 318 shares during the period. Sivia Capital Partners LLC grew its holdings in Cigna Group by 10.4% during the second quarter. Sivia Capital Partners LLC now owns 1,160 shares of the health services provider’s stock worth $384,000 after acquiring an additional 109 shares during the period. NewEdge Advisors LLC grew its holdings in Cigna Group by 4.5% during the second quarter. NewEdge Advisors LLC now owns 22,225 shares of the health services provider’s stock worth $7,347,000 after acquiring an additional 958 shares during the period. Treasurer of the State of North Carolina grew its holdings in Cigna Group by 16.6% during the second quarter. Treasurer of the State of North Carolina now owns 148,840 shares of the health services provider’s stock worth $49,204,000 after acquiring an additional 21,173 shares during the period. Finally, Osterweis Capital Management Inc. acquired a new position in Cigna Group during the second quarter worth $163,000. Institutional investors and hedge funds own 86.99% of the company’s stock.

Cigna Group Trading Down 0.9%

NYSE:CI opened at $272.58 on Wednesday. Cigna Group has a 52-week low of $239.51 and a 52-week high of $350.00. The company has a quick ratio of 0.74, a current ratio of 0.74 and a debt-to-equity ratio of 0.74. The stock has a fifty day simple moving average of $276.37 and a 200-day simple moving average of $278.30. The company has a market capitalization of $71.83 billion, a PE ratio of 12.29, a price-to-earnings-growth ratio of 0.95 and a beta of 0.26.

Cigna Group (NYSE:CI) last released its quarterly earnings data on Thursday, February 5th. The health services provider reported $8.08 EPS for the quarter, topping the consensus estimate of $7.88 by $0.20. Cigna Group had a net margin of 2.17% and a return on equity of 19.46%. The business had revenue of $72.50 billion for the quarter, compared to analyst estimates of $69.53 billion. During the same period in the previous year, the firm earned $6.64 EPS. The business’s revenue for the quarter was up 10.4% compared to the same quarter last year. Cigna Group has set its FY 2026 guidance at 30.250- EPS. On average, equities research analysts expect that Cigna Group will post 29.77 earnings per share for the current fiscal year.

Cigna Group Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, March 19th. Investors of record on Thursday, March 5th were given a $1.56 dividend. The ex-dividend date was Thursday, March 5th. This represents a $6.24 annualized dividend and a dividend yield of 2.3%. This is a boost from Cigna Group’s previous quarterly dividend of $1.51. Cigna Group’s payout ratio is presently 28.13%.

Insider Activity

In related news, insider Everett Neville sold 1,719 shares of the business’s stock in a transaction dated Monday, March 2nd. The shares were sold at an average price of $288.91, for a total value of $496,636.29. Following the sale, the insider directly owned 5,670 shares in the company, valued at $1,638,119.70. The trade was a 23.26% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Nicole S. Jones sold 2,307 shares of the business’s stock in a transaction dated Monday, March 2nd. The stock was sold at an average price of $288.91, for a total transaction of $666,515.37. Following the completion of the sale, the insider owned 32,647 shares in the company, valued at $9,432,044.77. This represents a 6.60% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. 0.60% of the stock is owned by insiders.

Analysts Set New Price Targets

A number of research analysts recently weighed in on CI shares. TD Cowen upped their price objective on Cigna Group from $333.00 to $338.00 and gave the stock a “buy” rating in a report on Monday, February 9th. Wall Street Zen raised Cigna Group from a “hold” rating to a “buy” rating in a report on Saturday, February 7th. Piper Sandler dropped their price objective on Cigna Group from $374.00 to $370.00 and set an “overweight” rating on the stock in a report on Tuesday, March 3rd. Deutsche Bank Aktiengesellschaft upped their price objective on Cigna Group from $301.00 to $304.00 and gave the stock a “buy” rating in a report on Tuesday, February 10th. Finally, Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Cigna Group in a report on Monday, December 29th. One equities research analyst has rated the stock with a Strong Buy rating, sixteen have given a Buy rating and four have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $333.11.

Cigna Group Company Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.